Tobacco companies finally have to say smoking causes cancer

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

These statements may not be breaking news for oncologists and other physicians, who should have been aware of the lethal nature of cigarette smoking at least since the publication of the first Surgeon General’s report on Smoking and Health more than half a century ago. While the report generated front page headlines and led the network newscasts back in January 1964, the tobacco epidemic has continued, causing more than 20 million deaths in the U.S. in the decades since. Cigarette companies have persisted in using their legal, marketing, and propaganda tools to mislead and addict millions of consumers, including underage youth, for the sole purpose of increasing profits.

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe

YOU MAY BE INTERESTED IN

Physician-scientists by day, a funk-loving musical troupe by night. You may have seen The CheckPoints—a 13 member cover band with a three-piece brass section and Jim Allison on harmonica—movin’, groovin’, and gettin’ down as a mainstay closing act at ASCO, AACR, or the Society for Immunotherapy of Cancer annual meetings. 
At the 2026 Annual Meeting of the American Society of Clinical Oncology in Chicago, results from the phase III HARMONi-6 trial were presented at the plenary session and published simultaneously in The Lancet. The HARMONi-6 trial tested a novel bispecific antibody that engages PD-1 and VEGF (ivonescimab), given with platinum-doublet chemotherapy to patients with previously untreated advanced squamous non-small cell lung cancer. 
In 2026, more than 900 million people are estimated to be regularly using generative artificial intelligence—computer systems capable of creating human-like text, images, audio, video, and other original content. AI is becoming integrated into nearly every aspect of daily life. Health care is no exception. 
Cliff Douglas
Vice President for Tobacco Control at the American Cancer Society and an attorney
with 30 years’ experience in tobacco control advocacy and litigation.

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login